First-of-its-kind narcolepsy drug opens door to new therapies for the brain

TL;DR - Nature reports that Orzeyful, a first-of-its-kind narcolepsy drug, targets the disorder’s underlying cause rather than only managing symptoms. This mechanism could enable new therapies for other brain disorders.

• Orzeyful represents a shift toward disease-modifying narcolepsy treatment.
• Its approach may open broader therapeutic avenues in neuroscience.
• The provided excerpt does not include trial results, efficacy data, or mechanism details.